Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin in elderly CAP
NCT05133752Phase 4Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by TaiGen Biotechnology Co., Ltd.. Started Sep 2018; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT05133752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133752.